Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$183K Sell
1,780
-220
-11% -$24.8K 0.17% 214
2025
Q4
$251K Hold
2,000
0.24% 175
2025
Q3
$268K Sell
2,000
-1,615
-45% -$212K 0.2% 197
2025
Q2
$492K Hold
3,615
0.29% 121
2025
Q1
$480K Buy
+3,615
New +$460K 0.34% 111

Other funds holding ABT

Corient IA's ABT Position: Q1 2026 in Review

Corient IA reduced its Abbott (ABT) stake by 11% in Q1 2026, selling an estimated $24.8K and leaving 1,780 shares worth $183K. The position accounts for 0.17% of the portfolio, ranked #214.

Corient IA first reported a position in ABT in Q1 2025 and has held it in 5 quarters since. The position peaked at $492K in Q2 2025. 3,084 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Corient IA held 1,780 shares of Abbott worth $183K as of Q1 2026.
  • Corient IA sold 220 Abbott shares in Q1 2026, an estimated $24.8K.
  • Abbott made up 0.17% of Corient IA's portfolio in Q1 2026, its #214 holding.
  • Corient IA first reported a position in Abbott in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Abbott position peaked at $492K in Q2 2025.
  • 3,084 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.